228 related articles for article (PubMed ID: 9858413)
21. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.
Elmas M; Tras B; Kaya S; Bas AL; Yazar E; Yarsan E
Can J Vet Res; 2001 Jan; 65(1):64-7. PubMed ID: 11227198
[TBL] [Abstract][Full Text] [Related]
22. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
23. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
Ganière JP; Médaille C; Etoré F
Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study.
Toma S; Colombo S; Cornegliani L; Persico P; Galzerano M; Gianino MM; Noli C
J Small Anim Pract; 2008 Aug; 49(8):384-91. PubMed ID: 18631220
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.
Wildermuth BE; Griffin CE; Rosenkrantz WS; Boord MJ
J Am Anim Hosp Assoc; 2007; 43(6):337-41. PubMed ID: 17975216
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the clinical efficacy of pradofloxacin tablets for the treatment of canine pyoderma.
Restrepo C; Ihrke PJ; White SD; Spiegel IB; Affolter VK
J Am Anim Hosp Assoc; 2010; 46(5):301-11. PubMed ID: 20810550
[TBL] [Abstract][Full Text] [Related]
27. Disposition of single-dose intravenously administered enrofloxacin in emus (Dromaius novaehollandiae).
Helmick KE; Boothe DM; Jensen JM
J Zoo Wildl Med; 1997 Mar; 28(1):43-8. PubMed ID: 9226615
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.
Ganiere JP; Medaille C; Mangion C
J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance of Staphylococcus pseudintermedius isolates from healthy dogs and dogs affected with pyoderma in Japan.
Onuma K; Tanabe T; Sato H
Vet Dermatol; 2012 Feb; 23(1):17-22, e5. PubMed ID: 21745248
[TBL] [Abstract][Full Text] [Related]
30. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
Soliman GA
Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
[TBL] [Abstract][Full Text] [Related]
31. Multifocal papular deep bacterial pyoderma in a Boxer dog caused by Pseudomonas aeruginosa.
Baxter CG; Vogelnest LJ
Aust Vet J; 2008 Nov; 86(11):435-9. PubMed ID: 18959531
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs.
Bloom PB; Rosser EJ
J Am Anim Hosp Assoc; 2001; 37(6):537-42. PubMed ID: 11716027
[TBL] [Abstract][Full Text] [Related]
33. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
[TBL] [Abstract][Full Text] [Related]
34. Disposition of enrofloxacin and its metabolite ciprofloxacin after intramuscular injection in juvenile Burmese pythons (Python molurus bivittatus).
Young LA; Schumacher J; Papich MG; Jacobson ER
J Zoo Wildl Med; 1997 Mar; 28(1):71-9. PubMed ID: 9226619
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD; Kelbick NT
Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
[TBL] [Abstract][Full Text] [Related]
36. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Regnier A; Schneider M; Concordet D; Toutain PL
Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a single intravenous enrofloxacin dose in scimitar-horned oryx (Oryx dammah).
Gamble KC; Boothe DM; Jensen JM; Heatley JJ; Helmick KE
J Zoo Wildl Med; 1997 Mar; 28(1):36-42. PubMed ID: 9226614
[TBL] [Abstract][Full Text] [Related]
38. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
Cabanes A; Reig F; Antón JM; Arboix M
Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
[TBL] [Abstract][Full Text] [Related]
39. Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 cases.
Hillier A; Alcorn JR; Cole LK; Kowalski JJ
Vet Dermatol; 2006 Dec; 17(6):432-9. PubMed ID: 17083575
[TBL] [Abstract][Full Text] [Related]
40. Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma, and dogs with a single episode of pyoderma.
Burkett G; Frank LA
J Am Vet Med Assoc; 1998 Jul; 213(2):232-4. PubMed ID: 9676593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
